Company: KNRX
Filing Date: 2025-08-21
Form Type: F-1/A
Source: 0001641172-25-025066
Chunk: 76

Company: KNOREX LTD.
Filing Date: 2025-08-21
Form: F-1/A
Chunk 76
---
 our Company’s initial public offering). The expiration dates of the warrants described in (i) and (ii) ranged from
December 2024 to December 2026. In January 2025, a total of 164,713 warrants described in (i) above were exercised to subscribe for 164,713 Class A Ordinary Shares with the remaining 4,527,387 warrants being cancelled in exchange for the issuance of a total of 4,527,387 warrants with an aggregate amount of US$7,073,397.74 to extend the expiration dates to a period range from March 2026 to December 2027.The expiration dates of the warrants described
in (ii) were extended to March 2027. The exercise
price for the warrants described in (ii) above with an aggregate amount of US$836,597 shall be determined by reference to the issue price
of the types of securities and shall be equal to the issue price of the securities being offered in the next immediate equity funding
round (or equal to 65% of the issue price of Class A Ordinary Shares if the next immediate equity funding round is the Company’s
initial public offering), subject to adjustment for certain dilutive events such as, among other things, subdivision, reclassification,
redenomination, conversion or consolidation of securities, capitalization, capital distribution, and rights issue. The maximum number
of shares that each of these warrant holders may subscribe for shall be determined by dividing the sum of the maximum subscription sum
of the relevant warrant holder by the exercise price, as adjusted for dilutive event(s) where applicable, corrected up to the nearest
whole number. In June 2025, the Company issued to a lender a total of 100,000 warrants with an aggregate value of US$260,000 in consideration
for providing a loan to the Company. The warrants will expire in June 2027. For details, see “Description of Share Capital—Warrants”
in this prospectus.

The chart below illustrates our corporate structure as of the date of this prospectus:

| 40 |

<div align='center'>MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</div>

You should read the following discussion and analysis of our financial condition and results of operations in conjunction with the section entitled “Selected Consolidated Financial and Operating Data” and our consolidated financial statements and the related notes included elsewhere in this prospectus. This discussion contains forward-looking statements that involve risks and uncertainties